共 50 条
- [41] Time to EGFR-TKI Treatment for Patients with Advanced NSCLC and EGFR Activating Mutation in a Tertiary Cancer CenterJOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1229 - S1229Le Guevelou, JenniferDugue, AudreyRichard, NicolasDubos, CatherineDo, PascalDanhier, SergeLerouge, DelphineBonneau, JessicaBlanc, CecileGervais, Radj
- [42] EGFR plasma mutation in prediction models for resistance with EGFR TKI and survival of non-small cell lung cancerCLINICAL AND TRANSLATIONAL MEDICINE, 2019, 8Thang Thanh PhanBich-Thu TranSon Truong NguyenToan Trong HoHang Thuy NguyenVu Thuong LeAnh Tuan Le
- [43] EGFR-TKI is effective regardless of treatment timing in pulmonary adenocarcinoma with EGFR mutationCANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 75 (01) : 197 - 206Koo, Dong-HoeKim, Kyu-pyoChoi, Chang-MinLee, Dae-HoLee, Jae CheolLee, Jung-ShinJang, Se JinKim, Sang-We
- [44] Novel two mechanisms for acquired EGFR-TKI resistance in lung cancer cells harboring EGFR activating mutationEUROPEAN RESPIRATORY JOURNAL, 2014, 44Izumi, HirotoKanda, RinaMurakami, YuichiMorimoto, YasuoOno, Mayumi
- [45] EGFR mutation type and efficacy of afatinib in patients who previously treated with EGFR-TKI.JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)Yosuke, KawashimaKitazono, SatoruTakano, NatsukiOguri, TomoyoTambo, YuichiYanagitani, NorikoHoriike, AtsushiOhyanagi, FumiyoshiHorai, TakeshiNishio, Makoto
- [46] Novel two mechanisms for acquired EGFR-TKI resistance in lung cancer cells harboring EGFR activating mutationEUROPEAN RESPIRATORY JOURNAL, 2014, 44Izumi, HirotoKanda, RinaMurakami, YuichiMorimoto, YasuoOno, Mayumi
- [48] Association of EGFR Exon 19 Deletion and EGFR-TKI Treatment Duration with Frequency of T790M Mutation in EGFR-Mutant Lung Cancer PatientsSCIENTIFIC REPORTS, 2016, 6Matsuo, NorikazuAzuma, KoichiSakai, KazukoHattori, SatoshiKawahara, AkihikoIshii, HidenobuTokito, TakaakiKinoshita, TakashiYamada, KazuhikoNishio, KazutoHoshino, Tomoaki
- [49] Association of EGFR Exon 19 Deletion and EGFR-TKI Treatment Duration with Frequency of T790M Mutation in EGFR-Mutant Lung Cancer PatientsScientific Reports, 6Norikazu MatsuoKoichi AzumaKazuko SakaiSatoshi HattoriAkihiko KawaharaHidenobu IshiiTakaaki TokitoTakashi KinoshitaKazuhiko YamadaKazuto NishioTomoaki Hoshino
- [50] Different first line EGFR-TKI regimen and the clearance of EGFR sensitive mutation in acquired EGFR-TKI resistant lung adenocarcinoma patientsANNALS OF ONCOLOGY, 2017, 28Zhuang, W.Xu, C.Wang, W.Song, Z.Zhu, Y.Chen, R.Guan, Y.Yi, X.Fang, M.Chen, G.Lv, T.Song, Y.